Ireland M&A Half-Year Review | 2023

ReportData Insight 14 August

Ireland M&A Half-Year Review | 2023

In line with international deal activity, Ireland’s mergers and acquisitions M&A market slowed in the first half of 2023

This report provides a comprehensive overview of developments in the Irish M&A market during the first half of 2023 and offers insight into the outlook for the rest of the year.

Highlights include:

  • Despite some positive macro-economic indicators (at least in relative terms), the Irish M&A market has inevitably been impacted by the global slowdown in activity. The first six months of 2023 saw 177 deals involving Irish businesses, collectively worth just over €5.2bn. Year-on-year (YoY), that represents a minor decline of 2% in volume and a more substantial -58% decrease by value.
  • The shape of Ireland’s M&A market in the first half of the year was similar to previous years, with 97% of transactions falling into the mid-market segment; of the 51 first-half deals where the value was disclosed, 45 of them were valued at between €5m and €250m.
  • The top end of the market however was particularly quiet, with just three deals worth more than €500m announced during the first half. The biggest recorded deal of all saw Chiesi Farmaceutici agree to pay €1.34bn for Irish head-quartered Amryt Pharma, another sign of the influence of the international pharmaceutical sector on Irish M&A statistics in recent years.

The report is also available via

Did you enjoy this article?

Add the following topics to your interests and we'll recommend articles based on these interests.

Public M&A Private Equity

In association with